The Diet Pills Market is predicted to reach US$ 1.3 billion by 2030 from US$ 1.3 billion in 2021, and to grow at a CAGR of ~ 9.8% between the forecast period 2022 to 2030.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Product Type (Over the Counter and Prescription), by Application (Fat Blocking and Appetite Suppression), by Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies) -
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Novo Nordisk A/S, Gelesis, Zoller Laboratories, GlaxoSmithKline plc, Chong's Health Care, Herbalife Limited, Currax Pharmaceuticals LLC, Arena Pharmaceuticals, Nutrisystem Limited, and F. Hoffmann-La Roche Ltd. among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Diet Pills - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Diet Pills - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Diet Pills - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Diet Pills - ANALYSIS & FORECAST, BY REGION
North America Diet Pills
1. North America Diet Pills , by Country
1. US
2. Canada
1. North America Diet Pills , by Product
2. North America Diet Pills , by Type
3. North America Diet Pills , by Gender
4. North America Diet Pills , by Sales Channel
3. Europe Diet Pills
1. Europe Diet Pills , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Diet Pills , by Product
3. Europe Diet Pills , by Type
4. Europe Diet Pills , by Gender
5. Europe Diet Pills , by Sales Channel
4. Asia Pacific Diet Pills
1. Asia Pacific Diet Pills , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Diet Pills , by product
3. Asia Pacific Diet Pills , by Type
4. Asia Pacific Diet Pills , by Gender
5. Asia Pacific Diet Pills , by Sales Channel
5. Rest of the World Diet Pills
1. Rest of the World Diet Pills , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Diet Pills , by Product
3. Rest of the World Diet Pills , by Type
4. Rest of the World Diet Pills , by Gender
5. Rest of the World Diet Pills , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 75